American College of Cardiology CEO Shalom “Shal” Jacobovitz is leaving the organization in February to lead CiVi Biopharma, a privately held biopharmaceutical company founded in 2016. The ACC and CiVi Biopharma both announced the move Jan. 3 with press releases.

A 2.3 percent excise tax on medical device manufacturers went back into effect Jan. 1 after a two-year suspension. According to an Associated Press article, industry groups estimate the tax will cost $20 billion over the next decade.

Uber’s presence has decreased ambulance usage by at least 7 percent per capita in the cities that offer the ride-sharing service, according to a study published in October.

Making healthier changes to school lunch policies is like the battle an individual endures when starting a new diet. It’s unpleasant and unpopular at first, but worth it if you stick with it.

After taking a week off from his ABC late-night show while his 8-month-old son, Billy, recovered from a second heart surgery, Jimmy Kimmel returned to the air Dec. 11 with Billy in his arms.

Consumers are increasingly paying more for drugs through health insurance than they would if they found the best deal on their own, according to an article published jointly by The New York Times and ProPublica.

Edwards Lifesciences has purchased Baltimore-based Harpoon Medical for an initial $100 million, with the potential for up to $150 million more to be disbursed in milestone-driven payments over the next 10 years. Edwards announced the acquisition Dec. 6, hailing the addition of Harpoon’s mitral valve repair device to its product line.

Low- to middle-income countries (LMICs) spend billions of collective dollars each year on healthcare, Journal of the American College of Cardiology editor-in-chief Valentin Fuster, MD, PhD, and colleagues wrote in a recent JACC article—but they aren’t necessarily spending those funds effectively.